Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 2/2004

01.02.2004 | Original Article

Heterogeneity of cerebral blood flow in frontotemporal lobar degeneration and Alzheimer’s disease

verfasst von: Michinobu Nagao, Yoshifumi Sugawara, Manabu Ikeda, Ryuji Fukuhara, Kazuhiko Hokoishi, Kenya Murase, Teruhito Mochizuki, Hitoshi Miki, Takanori Kikuchi

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 2/2004

Einloggen, um Zugang zu erhalten

Abstract

This study was designed to quantify the heterogeneity on cerebral blood flow single-photon emission tomography (SPET) images in frontotemporal lobar degeneration (FTLD) and Alzheimer’s disease (AD) using a three-dimensional fractal analysis. Twenty-one FTLD patients, 21 AD patients and 11 healthy controls underwent technetium-99m hexamethylpropylene amine oxime SPET scanning. Patients with FTLD and AD matched for sex, age and the severity of dementia as estimated with the Clinical Dementia Rating and were determined to be in the early stage of illness. We delineated the SPET images using a 35% cut-off and a 50% cut-off of the maximal voxel radioactivity and measured the number of voxels included in the contours of two different cut-offs. The fractal dimension (FD) was calculated by relating the logarithms of the cut-offs and the numbers of voxels, and it was defined as the heterogeneity of the cerebral perfusion. We divided the SPET images into two sets, anterior and posterior, with equal numbers of coronal SPET slices. We calculated total FD, anterior FD and posterior FD for total, anterior and posterior SPET images. Anterior FDs for FTLD and AD were 1.55±0.34 and 1.24±0.19 (P=0.0002). The ratios of anterior to posterior FD for FTLD and AD were 1.81±0.41 and 1.32±0.14 (P<0.0001). Use of the anterior FD and the ratio of anterior to posterior FD separated FTLD patients from AD patients and controls with a sensitivity of 85.7% and a specificity of 93.8%. Anterior FD and the ratio of anterior to posterior FD may be useful in distinguishing FTLD from AD.
Literatur
1.
Zurück zum Zitat Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51:1546–1554.PubMed Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51:1546–1554.PubMed
2.
Zurück zum Zitat The Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994; 57:416–418.PubMed The Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994; 57:416–418.PubMed
3.
Zurück zum Zitat Knopman DS, Mastri AR, Frey WH, Sung JH, Rustan BA. Dementia lacking distinctive histologic feature: a common non-Alzheimer degenerative dementia. Neurology 1990; 40:251–256.PubMed Knopman DS, Mastri AR, Frey WH, Sung JH, Rustan BA. Dementia lacking distinctive histologic feature: a common non-Alzheimer degenerative dementia. Neurology 1990; 40:251–256.PubMed
4.
Zurück zum Zitat Gustafson L. Clinical picture of frontal lobe degeneration of non-Alzheimer type. Dementia 1993; 4:143–148.PubMed Gustafson L. Clinical picture of frontal lobe degeneration of non-Alzheimer type. Dementia 1993; 4:143–148.PubMed
5.
Zurück zum Zitat Neary D, Snowden JS, Northen B, Goulding P. Dementia of the frontal lobe type. J Neurol Neurosurg Psychiatry 1988; 51:353–361.PubMed Neary D, Snowden JS, Northen B, Goulding P. Dementia of the frontal lobe type. J Neurol Neurosurg Psychiatry 1988; 51:353–361.PubMed
6.
Zurück zum Zitat Miller BL, Cummings JL, Villanueva-Meyer J, et al. Frontal lobe degeneration: clinical, neuropsychological, and SPECT characteristics. Neurology 1991; 41:1347–1382. Miller BL, Cummings JL, Villanueva-Meyer J, et al. Frontal lobe degeneration: clinical, neuropsychological, and SPECT characteristics. Neurology 1991; 41:1347–1382.
7.
Zurück zum Zitat Launes J, Sulkava R, Erkinjuntti T, et al. Technetium-99m HMPAO SPECT in suspected dementia. Nucl Med Commun 1991; 12:757–765.PubMed Launes J, Sulkava R, Erkinjuntti T, et al. Technetium-99m HMPAO SPECT in suspected dementia. Nucl Med Commun 1991; 12:757–765.PubMed
8.
Zurück zum Zitat Minoshima S, Giordani B, Frey KA, et al. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer’s disease. Ann Neurol. 1997; 42:85–94. Minoshima S, Giordani B, Frey KA, et al. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer’s disease. Ann Neurol. 1997; 42:85–94.
9.
Zurück zum Zitat Imran MB, Kawashima R, Awata S, et al. Parametric mapping of cerebral blood flow deficits in Alzheimer’s disease: a SPECT study using HMPAO and image standardization technique. J Nucl Med 1999; 40:244–249.PubMed Imran MB, Kawashima R, Awata S, et al. Parametric mapping of cerebral blood flow deficits in Alzheimer’s disease: a SPECT study using HMPAO and image standardization technique. J Nucl Med 1999; 40:244–249.PubMed
10.
Zurück zum Zitat Holman BL, Johnson KA, Gerada B, et al. The scintigraphic appearance of Alzheimer’s disease: a prospective study using Tc-99m HMPAO SPECT. J Nucl Med 1992; 33:181–185.PubMed Holman BL, Johnson KA, Gerada B, et al. The scintigraphic appearance of Alzheimer’s disease: a prospective study using Tc-99m HMPAO SPECT. J Nucl Med 1992; 33:181–185.PubMed
11.
Zurück zum Zitat Messa C, Perani D, Lucignani G, et al. High-resolution technetium-99m HMPAO SPECT in patients with probable Alzheimer’s disease: comparison with fluorine-18-FDG-PET. J Nucl Med 1994; 35:210–216.PubMed Messa C, Perani D, Lucignani G, et al. High-resolution technetium-99m HMPAO SPECT in patients with probable Alzheimer’s disease: comparison with fluorine-18-FDG-PET. J Nucl Med 1994; 35:210–216.PubMed
12.
Zurück zum Zitat Ohnishi T, Hoshi H, Nagamachi R, et al. High-resolution SPECT to assess hippocampal perfusion in neuropsychiatric diseases. J Nucl Med 1995; 36:1163–1169.PubMed Ohnishi T, Hoshi H, Nagamachi R, et al. High-resolution SPECT to assess hippocampal perfusion in neuropsychiatric diseases. J Nucl Med 1995; 36:1163–1169.PubMed
13.
Zurück zum Zitat Gustafson L. Frontal lobe degeneration of non-Alzheimer type. Clinical picture and differential diagnosis. Arch Gerontol Geriatr 1987; 6:209–223.PubMed Gustafson L. Frontal lobe degeneration of non-Alzheimer type. Clinical picture and differential diagnosis. Arch Gerontol Geriatr 1987; 6:209–223.PubMed
14.
Zurück zum Zitat Holman BL, Devous MD Sr. Functional brain SPECT: the emergence of a powerful clinical method. J Nucl Med 1992; 33:1888–1904.PubMed Holman BL, Devous MD Sr. Functional brain SPECT: the emergence of a powerful clinical method. J Nucl Med 1992; 33:1888–1904.PubMed
15.
Zurück zum Zitat Pickut BA, Saerens J, Marien P, et al. Discriminative use of SPECT in frontal lobe-type dementia versus (senile) dementia of the Alzheimer’s type. J Nucl Med 1997; 38: 929–934.PubMed Pickut BA, Saerens J, Marien P, et al. Discriminative use of SPECT in frontal lobe-type dementia versus (senile) dementia of the Alzheimer’s type. J Nucl Med 1997; 38: 929–934.PubMed
16.
Zurück zum Zitat Nagao M, Murase K, Kikuchi T, et al. Fractal analysis of cerebral blood flow distribution in Alzheimer’s disease. J Nucl Med 2001; 42:1446–1450.PubMed Nagao M, Murase K, Kikuchi T, et al. Fractal analysis of cerebral blood flow distribution in Alzheimer’s disease. J Nucl Med 2001; 42:1446–1450.PubMed
17.
Zurück zum Zitat Hokoishi K, Ikeda M, Maki N, et al. Frontotemporal lobar degeneration: a study in Japan. Dement Geriatr Cogn Disord 2001; 12:393–399.CrossRefPubMed Hokoishi K, Ikeda M, Maki N, et al. Frontotemporal lobar degeneration: a study in Japan. Dement Geriatr Cogn Disord 2001; 12:393–399.CrossRefPubMed
18.
Zurück zum Zitat Folstein MF, Folstein SE, McHugh PR. Mini-Mental State. A practical method for grading the cognitive state of patients for clinician. J Psychiat Res 1975; 12:189–198.CrossRefPubMed Folstein MF, Folstein SE, McHugh PR. Mini-Mental State. A practical method for grading the cognitive state of patients for clinician. J Psychiat Res 1975; 12:189–198.CrossRefPubMed
19.
Zurück zum Zitat Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer’s disease. Am J Psychiatry 1984; 141:1356–1364.PubMed Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer’s disease. Am J Psychiatry 1984; 141:1356–1364.PubMed
20.
Zurück zum Zitat Morris JC. The Clinical Dementia Rating (CDR): current version and screening rules. Neurology 1993; 43:2412–2414. Morris JC. The Clinical Dementia Rating (CDR): current version and screening rules. Neurology 1993; 43:2412–2414.
21.
Zurück zum Zitat McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984; 34:939–944.PubMed McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984; 34:939–944.PubMed
22.
Zurück zum Zitat Mandelbrot B. How long is the coast of Britain? Statistical self-similarity and fractal dimension. Science 1967; 156:636–638. Mandelbrot B. How long is the coast of Britain? Statistical self-similarity and fractal dimension. Science 1967; 156:636–638.
23.
Zurück zum Zitat Nelson T. Fractal physiologic complexity, scaling, and opportunities for imaging. Invest Radiol 1990; 25:1140–1148.PubMed Nelson T. Fractal physiologic complexity, scaling, and opportunities for imaging. Invest Radiol 1990; 25:1140–1148.PubMed
24.
Zurück zum Zitat Chung HW, Huang YH. Fractal analysis of nuclear medicine images for the diagnosis of pulmonary emphysema: interpretations, implications, and limitations. AJR 2000; 174:1055–1059. Chung HW, Huang YH. Fractal analysis of nuclear medicine images for the diagnosis of pulmonary emphysema: interpretations, implications, and limitations. AJR 2000; 174:1055–1059.
25.
Zurück zum Zitat Nagao M, Murase K. Measurement of heterogeneous distribution on Technegas SPECT images by three-dimensional fractal analysis. Ann Nucl Med 2002; 16:369–376.PubMed Nagao M, Murase K. Measurement of heterogeneous distribution on Technegas SPECT images by three-dimensional fractal analysis. Ann Nucl Med 2002; 16:369–376.PubMed
26.
Zurück zum Zitat Snowden JS, Neary D, Mann DMA. Fronto-temporal lobar degeneration: fronto-temporal dementia, progressive aphasia, sematic dementia. New York: Livingstone, 1996. Snowden JS, Neary D, Mann DMA. Fronto-temporal lobar degeneration: fronto-temporal dementia, progressive aphasia, sematic dementia. New York: Livingstone, 1996.
27.
Zurück zum Zitat Ishii K, Sakamoto S, Sasaki M, et al. Cerebral glucose metabolism in patients with frontotemporal dementia. J Nucl Med 1998; 39:1875–1878.PubMed Ishii K, Sakamoto S, Sasaki M, et al. Cerebral glucose metabolism in patients with frontotemporal dementia. J Nucl Med 1998; 39:1875–1878.PubMed
28.
Zurück zum Zitat Kitagaki H, Mori E, Hirono N, et al. Alteration of white matter MR signal intensity in frontotemporal dementia. Am J Neuroradiol 1997; 18:367–378.PubMed Kitagaki H, Mori E, Hirono N, et al. Alteration of white matter MR signal intensity in frontotemporal dementia. Am J Neuroradiol 1997; 18:367–378.PubMed
29.
Zurück zum Zitat DeKosky ST, Harbaugh RE, Schmitt FA, et al. The Intraventricular Bethanecol Study Group: cortical biopsy in Alzheimer’s disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Ann Neurol 1992; 32:625–632.PubMed DeKosky ST, Harbaugh RE, Schmitt FA, et al. The Intraventricular Bethanecol Study Group: cortical biopsy in Alzheimer’s disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Ann Neurol 1992; 32:625–632.PubMed
30.
Zurück zum Zitat Meyer M, Koeppe RA, Frey KA, et al. Positron emission tomography measures of benzodiazepine binding in Alzheimer’s disease. Arch Neurol 1995; 52:314–317.PubMed Meyer M, Koeppe RA, Frey KA, et al. Positron emission tomography measures of benzodiazepine binding in Alzheimer’s disease. Arch Neurol 1995; 52:314–317.PubMed
31.
Zurück zum Zitat Terry RD, Peck A, Deteresa R, et al. Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol 1981; 10:184–192.PubMed Terry RD, Peck A, Deteresa R, et al. Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol 1981; 10:184–192.PubMed
32.
Zurück zum Zitat Rogers J, Morrison JH. Quantitative morphology and regional and laminar distribution of senile plaques in Alzheimer’s disease. J Neurosci 1985; 5:2801–2808.PubMed Rogers J, Morrison JH. Quantitative morphology and regional and laminar distribution of senile plaques in Alzheimer’s disease. J Neurosci 1985; 5:2801–2808.PubMed
33.
Zurück zum Zitat Kuikka JT, Bassingthwaighte JB, Henrich MM. Mathematical modeling in nuclear medicine. Eur J Nucl Med 1991; 18:351–361.PubMed Kuikka JT, Bassingthwaighte JB, Henrich MM. Mathematical modeling in nuclear medicine. Eur J Nucl Med 1991; 18:351–361.PubMed
34.
Zurück zum Zitat Kuikka JT. Effect of tissue heterogeneity on quantification in positron emission tomography. Eur J Nucl Med 1995; 22:1457–1458.PubMed Kuikka JT. Effect of tissue heterogeneity on quantification in positron emission tomography. Eur J Nucl Med 1995; 22:1457–1458.PubMed
35.
Zurück zum Zitat Yoshikawa T, Murase K, Oku N, et al. Statistical image analysis of cerebral blood flow in vascular dementia with small-vessels disease. J Nucl Med 2003; 44:505–511.PubMed Yoshikawa T, Murase K, Oku N, et al. Statistical image analysis of cerebral blood flow in vascular dementia with small-vessels disease. J Nucl Med 2003; 44:505–511.PubMed
36.
Zurück zum Zitat Page MP, Howard RJ, O’Brien JT, Buxton-Thomas MS, Pickering AD. Use of neural networks in brain SPECT to diagnose Alzheimer’s disease. J Nucl Med 1996; 37:195–200.PubMed Page MP, Howard RJ, O’Brien JT, Buxton-Thomas MS, Pickering AD. Use of neural networks in brain SPECT to diagnose Alzheimer’s disease. J Nucl Med 1996; 37:195–200.PubMed
37.
Zurück zum Zitat Hamilton D, O’Mahony D, Coffey J, et al. Classification of mild Alzheimer’s disease by artificial neural network analysis of SPET data. Nucl Med Commun 1997; 18:805–810.PubMed Hamilton D, O’Mahony D, Coffey J, et al. Classification of mild Alzheimer’s disease by artificial neural network analysis of SPET data. Nucl Med Commun 1997; 18:805–810.PubMed
Metadaten
Titel
Heterogeneity of cerebral blood flow in frontotemporal lobar degeneration and Alzheimer’s disease
verfasst von
Michinobu Nagao
Yoshifumi Sugawara
Manabu Ikeda
Ryuji Fukuhara
Kazuhiko Hokoishi
Kenya Murase
Teruhito Mochizuki
Hitoshi Miki
Takanori Kikuchi
Publikationsdatum
01.02.2004
Verlag
Springer-Verlag
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 2/2004
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-003-1343-6

Weitere Artikel der Ausgabe 2/2004

European Journal of Nuclear Medicine and Molecular Imaging 2/2004 Zur Ausgabe